Literature DB >> 12700950

Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic.

John Mendelsohn1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12700950     DOI： 10.1007/s00262-002-0354-7

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  17 in total

Review 1.  Current status of monoclonal antibodies as therapeutic agents for solid cancer.

Authors:  Chiaki Okuse; Fumio Itoh
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

2.  Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.

Authors:  D L Wheeler; S Huang; T J Kruser; M M Nechrebecki; E A Armstrong; S Benavente; V Gondi; K-T Hsu; P M Harari
Journal:  Oncogene       Date:  2008-02-25       Impact factor: 9.867

3.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

4.  Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.

Authors:  Adi F Gazdar; John D Minna
Journal:  Cancer Prev Res (Phila)       Date:  2008-08

5.  Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Authors:  Jeonghee Cho; Liang Chen; Naveen Sangji; Takafumi Okabe; Kimio Yonesaka; Joshua M Francis; Richard J Flavin; William Johnson; Jihyun Kwon; Soyoung Yu; Heidi Greulich; Bruce E Johnson; Michael J Eck; Pasi A Jänne; Kwok-Kin Wong; Matthew Meyerson
Journal:  Cancer Res       Date:  2013-09-24       Impact factor: 12.701

6.  Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.

Authors:  Hannah E Pearson; Mari Iida; Rachel A Orbuch; Nellie K McDaniel; Kwangok P Nickel; Randall J Kimple; Jack L Arbiser; Deric L Wheeler
Journal:  Mol Cancer Ther       Date:  2017-10-20       Impact factor: 6.261

Review 7.  Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.

Authors:  Paul M Harari; Deric L Wheeler; Jennifer R Grandis
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

Review 8.  ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Authors:  Jin-Qiang Chen; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-06-13

9.  Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patients.

Authors:  Jasmina Obradovic; Vladimir Jurisic
Journal:  Multidiscip Respir Med       Date:  2012-12-11

Review 10.  Immunotherapy for head and neck cancer.

Authors:  H Carter Davidson; Michael S Leibowitz; Andres Lopez-Albaitero; Robert L Ferris
Journal:  Oral Oncol       Date:  2009-05-12       Impact factor: 5.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.